United Kingdom Ulcerative Colitis Market 规模与份额分析 - 成长趋势与预测 (2024 - 2031)

United Kingdom Ulcerative Colitis Market is Segmented By Drug Type (Anti-Inflammatory Drugs, Anti-TNF biologics, Immuno-suppressants, Calcineurin Inhibitors, and Others), By Disease Type (Ulcerative Proctitis, Proctosigmoiditis, Left-sided Colitis, Pancolitis or Universal Colitis, and Fulminant Colitis), By Dosage Form (Parenteral and Oral), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies). The report offers the value (in USD million) for the above-mentioned segments.

United Kingdom Ulcerative Colitis Market Trends

  • 转向生物学: 近年来,联合王国的溃疡性结肠炎市场出现了从传统非专利药物向新型生物学疗法的明显转变。 几种针对参与溃疡性结膜炎炎炎过程的特定蛋白质或分子的生物学药物已经成为患者和医生中非常流行的治疗选择. 这些生物药物,如Humira,Stelara,和Entyvio,与临床试验中的非专利药物相比,显示出了高的诱导性和维持还原率. 因此,这些生物药物的处方和销售量在预测期间有了显著增长。

图 1. 2023年按地区分列的联合王国聚氨酯市场价值(Mn美元)

United Kingdom Ulcerative Colitis Market By Region